Latest news: May 2023

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to: communications@curiumpharma.com

Curium - life forward

26th May 2023

Curium receives positive CHMP opinion of PYLCLARI® for primary staging of patients with high-risk PCa prior to initial curative therapy and to localize recurrence of PCa in patients with a suspected recurrence based on increasing serum Prostate-Specific Antigen (PSA) levels after primary treatment with curative intent

Curium - life forward

23rd May 2023

Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T

Curium - life forward

2nd May 2023

Curasight and Curium announce global partnership for uTRACE® in prostate cancer